Health
The second study that tested a COVID-19 antibody has a setback – AlKhaleej Today
The second study that tested a COVID-19 antibody has a setback
For the second time, a study testing an experimental antibody drug for COVID-19 has been suspended to investigate a possible safety issue in hospitalized patients.Regeneron Pharmaceuticals Inc. said Friday that independent observers had recommended that the most critically ill patients those who require intensive oxygen treatment or breathing apparatus be put on hold because of a potential safety issue and an adverse balance of risks and benefits. The study can continue to test the combination of…
-
Business17 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business19 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
General16 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
Business16 hours agoHere’s what analysts expect for the BHP share price in the coming year